Phase II study of sunitinib in patients with recurrent and/or metastatic squamous head and neck carcinoma: The GORTEC 2006-01 study

被引：0
|
作者：
Machiels, J. H. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
Henry, S. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
Zanetta, S. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
Kaminsky, M. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
Michoux, N. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
Bompas, E. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
Dillies, A. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
Faivre, S. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
Schmitz, S. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
Guigay, J. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ,9 ]
机构：
[1] Catholic Univ Louvain, B-1200 Brussels, Belgium
[2] Mont Godinne UCL Yvoir, Yvoir, Belgium
[3] Clin St Elizabeth, Namur, Belgium
[4] Ctr George Francois Leclerc, Dijon, France
[5] Ctr Alexis Vautrin, Nancy, France
[6] Ctr Rene Gauducheau, St Herblain, France
[7] Ctr Jean Perrin, Clermont Ferrand, France
[8] Hop Beaujon, AP HP, Paris, France
[9] Inst Gustave Roussy, Villejuif, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6024
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Phase II Study of Sunitinib in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: GORTEC 2006-01
    Machiels, Jean-Pascal H.
    Henry, Stephanie
    Zanetta, Sylvie
    Kaminsky, Marie-Christine
    Michoux, Nicolas
    Rommel, Denis
    Schmitz, Sandra
    Bompas, Emmanuelle
    Dillies, Anne-Francoise
    Faivre, Sandrine
    Moxhon, Anne
    Duprez, Thierry
    Guigay, Joel
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (01) : 21 - 28
  • [2] Phase II study of figitumumab in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: GORTEC 2008-02
    Schmitz, S.
    Kaminsky-Forrett, M.
    Henry, S.
    Zanetta, S.
    Geoffrois, L.
    Bompas, E.
    Moxhon, A.
    Guigay, J.
    Machiels, J. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [3] Phase II trial of sunitinib in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN)
    Choong, N. W.
    Cohen, E. E.
    Kozloff, M. F.
    Taber, D.
    Wade, J. L., III
    Hu, S.
    Ivy, S. P.
    Nichols, K.
    Dekker, A.
    Vokes, E. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [4] A phase II study of poziotinib in patients with recurrent and/or metastatic head and neck squamous cell carcinoma
    Lee, Ji Hyun
    Heo, Seong Gu
    Ahn, Beung-Chul
    Hong, Min Hee
    Cho, Byoung Chul
    Lim, Sun Min
    Kim, Hye Ryun
    CANCER MEDICINE, 2021, 10 (20): : 7012 - 7020
  • [5] Phase II study of ispinesib in recurrent or metastatic squamous cell carcinoma of the head and neck
    Tang, Patricia A.
    Siu, Lillian L.
    Chen, Eric X.
    Hotte, Sebastien J.
    Chia, Stephen
    Schwarz, James K.
    Pond, Gregory R.
    Johnson, Caitlin
    Colevas, A. Dimitrios
    Synold, Timothy W.
    Vasist, Lakshmi S.
    Winquist, Eric
    INVESTIGATIONAL NEW DRUGS, 2008, 26 (03) : 257 - 264
  • [6] A Phase II Study of Lapatinib in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
    de Souza, Jonas A.
    Davis, Darren W.
    Zhang, Yujian
    Khattri, Arun
    Seiwert, Tanguy Y.
    Aktolga, Serdal
    Wong, Stuart J.
    Kozloff, Mark F.
    Nattam, Sreenivasa
    Lingen, Mark W.
    Kunnavakkam, Rangesh
    Stenson, Kerstin M.
    Blair, Elizabeth A.
    Bozeman, Jeffrey
    Dancey, Janet E.
    Vokes, Everett E.
    Cohen, Ezra E. W.
    CLINICAL CANCER RESEARCH, 2012, 18 (08) : 2336 - 2343
  • [7] Phase II study of ispinesib in recurrent or metastatic squamous cell carcinoma of the head and neck
    Patricia A. Tang
    Lillian L. Siu
    Eric X. Chen
    Sebastien J. Hotte
    Stephen Chia
    James K. Schwarz
    Gregory R. Pond
    Caitlin Johnson
    A. Dimitrios Colevas
    Timothy W. Synold
    Lakshmi S. Vasist
    Eric Winquist
    Investigational New Drugs, 2008, 26 : 257 - 264
  • [8] Cetuximab, docetaxel, and cisplatin as first-line treatment in patients with recurrent or metastatic head and neck squamous cell carcinoma: a multicenter, phase II GORTEC study
    Guigay, J.
    Fayette, J.
    Dillies, A. F.
    Sire, C.
    Kerger, J. N.
    Tennevet, I.
    Machiels, J. P.
    Zanetta, S.
    Pointreau, Y.
    Bozec Le Moal, L.
    Henry, S.
    Schilf, A.
    Bourhis, J.
    ANNALS OF ONCOLOGY, 2015, 26 (09) : 1941 - 1947
  • [9] Phase II study of figitumumab in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: clinical activity and molecular response (GORTEC 2008-02)
    Schmitz, S.
    Kaminsky-Forrett, M. -C.
    Henry, S.
    Zanetta, S.
    Geoffrois, L.
    Bompas, E.
    Moxhon, A.
    Mignion, L.
    Guigay, J.
    Knoops, L.
    Hamoir, M.
    Machiels, J. -P.
    ANNALS OF ONCOLOGY, 2012, 23 (08) : 2153 - 2161
  • [10] Phase II study of sunitinib malate in head and neck squamous cell carcinoma
    Choong, Nicholas W.
    Kozloff, Mark
    Taber, David
    Hu, H. Shawn
    Wade, James, III
    Ivy, Percy
    Karrison, Theodore G.
    Dekker, Allison
    Vokes, Everett E.
    Cohen, Ezra E. W.
    INVESTIGATIONAL NEW DRUGS, 2010, 28 (05) : 677 - 683
12345